Articles

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

School of Life Sciences, Jilin University, Changchun, China;
School of Life Sciences, Jilin University, Changchun, China;
Cancer Biology Graduate Program, Wayne State University School of Medicine, Detroit, MI, USA;
Department of Biological Sciences, Oakland University, Rochester, MI, USA;
Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA;
Dept of Pediatrics, Children's Hospital of Michigan, Wayne State University, Detroit, MI, USA;
Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA;
Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA;
Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA;
Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA;
Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA;
Department of Biological Sciences, Oakland University, Rochester, MI, USA;
School of Life Sciences, Jilin University, Changchun, China;
Department of Rehabilitation, School of Nursing, Jilin University, Changchun, China;
Dept. of Pediatric Hematology & Oncology, First Hospital of Jilin University, Changchun, China;
Dept. of Hematology and Oncology, The First Hospital of Jilin University, Changchun, China;
Dept of Pediatrics, Children Hospital of Michigan, Wayne State University, Detroit, MI, USA;
Wayne State University School of Medicine, Detroit, MI, USA
Haematologica Early view Mar 12, 2020 https://doi.org/10.3324/haematol.2019.233445